Current Progress in the Clinical Management and Basic Science of Head and Neck Cancer

Dear Colleagues,

Every year, more than 800,000 patients are newly diagnosed with HNSCC worldwide and 450,000 patients with HNSCC die. Cigarette smoking, alcohol consumption, and viral infections are recognized as they major factors that can cause HNSCC. In addition to surgery and chemoradiotherapy, molecule-targeted therapy and immunotherapy are the main treatment options for HNSCC. As this area of basic and clinical research has rapidly progressed in recent years, it is important that clinicians understand the basic biology of HNSCC so that they are able to choose an appropriate therapy in the upcoming era of personalized medicine. In this Special Issue of Cancers, we welcome both original research and reviews regarding clinical advances in the treatment of HNSCC as well as basic research on its carcinogenesis, the tumor microenvironment and microbiome, and antitumor immunity. Reports of clinical experience or case series are also acceptable if they are related to particularly interesting topics within the field.

Dr. Takumi Kumai
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• head and neck cancer
• immunotherapy
• chemoradiotherapy
• surgery
• molecular biology
• oncogenesis
• cancer immunology